E11.3541 Type 2 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, right eye

Name of the Condition

• Common Name: Type 2 Diabetes with Proliferative Diabetic Retinopathy and Combined Retinal Detachment (Right Eye)
• Medical Term: Type 2 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, right eye

Summary

This condition is a severe complication of type 2 diabetes characterized by the growth of abnormal new blood vessels in the retina (proliferative diabetic retinopathy) and a combination of traction retinal detachment and rhegmatogenous retinal detachment in the right eye. It arises from prolonged high blood sugar levels damaging retinal blood vessels, potentially leading to vision impairment or blindness if untreated. The combination of proliferative changes and dual retinal detachment indicates advanced retinal damage requiring prompt management.

Causes

High blood sugar levels over time damage the small blood vessels in the retina, triggering the growth of fragile, abnormal blood vessels. These vessels can form scar tissue that pulls on the retina (traction detachment) and may also cause a tear or hole, leading to rhegmatogenous detachment. This process is driven by diabetes-related vascular changes and metabolic imbalances, which disrupt normal retinal function and structure.

Risk Factors

• Poorly controlled blood glucose levels.
• Long duration of diabetes.
• Hypertension and high cholesterol.
• Smoking and obesity.
• Family history of diabetic eye disease.

Symptoms

• Often asymptomatic in early stages.
• Blurred or distorted vision.
• Floaters or dark spots in the visual field.
• Sudden vision loss in severe cases.
• Visual field defects or shadowing.

Diagnosis

Diagnosis requires a comprehensive dilated eye exam by an ophthalmologist, often supplemented by fundus photography, fluorescein angiography, or optical coherence tomography (OCT). These tests help assess retinal blood vessel changes, detachment extent, and macular involvement. Imaging may confirm the presence of traction and rhegmatogenous components, guiding treatment decisions.

Treatment Options

Treatment focuses on stabilizing retinal detachment and managing proliferative changes. Options include laser photocoagulation to reduce abnormal vessel growth, vitrectomy surgery to remove scar tissue and repair detachment, and intraocular medications (e.g., anti-VEGF agents) to control neovascularization. Blood sugar and blood pressure management are critical to slow disease progression.

Prognosis and Follow-Up

Prognosis depends on the extent of retinal damage and timeliness of treatment. Early intervention can preserve vision, but advanced detachment may result in permanent vision loss. Regular follow-up with an ophthalmologist is essential to monitor for recurrence or complications, with frequency adjusted based on disease severity.

Complications

• Permanent vision loss or blindness.
• Recurrent retinal detachment.
• Glaucoma due to abnormal blood vessel growth.
• Cataracts (accelerated by diabetes).
• Macular edema (swelling in the central retina).

Lifestyle & Prevention

• Maintain strict blood glucose control through diet, exercise, and medication.
• Regular eye exams (at least annually) to detect early retinal changes.
• Manage blood pressure and cholesterol levels.
• Avoid smoking and limit alcohol intake.
• Protect eyes from injury and UV exposure.

When to Seek Professional Help

Seek immediate care if you experience sudden vision loss, increased floaters, or flashes of light, as these may indicate retinal detachment. Regular ophthalmologic evaluations are necessary for ongoing monitoring, even if symptoms are absent.

Tips for Medical Coders

Document the specific eye (right) and the combination of traction and rhegmatogenous retinal detachment to support accurate coding. Include details on diagnostic tests (e.g., OCT, angiography) and treatment interventions (e.g., vitrectomy, laser) to confirm the condition’s severity and guide code assignment. Ensure documentation aligns with clinical findings to reflect the advanced nature of the retinal detachment.